SVFD · Save Foods, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | $2.0K | - | $66.0K | - | $9.1K | $16.5K | $43.8K | - |
| Cost of Revenue | - | - | $2.0K | $2.0K | $14.0K | - | $76.8K | $5.8K | $28.0K | - |
| Gross Profit | - | - | $0 | ($2.0K) | $52.0K | - | ($67.7K) | $10.8K | $15.9K | - |
| R&D | $275.0K | - | $52.0K | $9.0K | $20.0K | - | $122.4K | $11.7K | $115.9K | - |
| SG&A | $1.90M | - | $1.24M | $2.77M | $604.0K | - | $1.29M | $808.3K | $741.8K | - |
| Total Operating Expenses | - | - | - | - | - | - | $1.98M | $302.6K | $308.7K | - |
| D&A | $3.0K | - | - | - | $3.0K | - | - | - | $5.1K | - |
| Operating Income | ($8.22M) | - | ($1.33M) | ($2.83M) | ($619.0K) | - | ($1.55M) | ($866.2K) | ($899.1K) | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | ($23.0K) | - | - | - | - | - | - | - | - | - |
| Net Income | ($6.58M) | - | $429.0K | ($4.51M) | ($1.19M) | - | ($2.26M) | ($787.4K) | ($769.6K) | - |
| EPS - Basic | ($10.74) | - | $0.45 | ($0.18) | ($0.07) | - | ($0.39) | ($0.23) | ($0.26) | - |
| EPS - Diluted | ($10.74) | - | $0.97 | ($0.18) | ($0.39) | - | ($0.39) | ($0.23) | ($0.26) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.30M | $3.83M | $6.04M | $3.14M | $2.72M | $2.19M | $2.75M | $4.47M | $3.49M | $4.45M |
| Accounts Receivable | $130.0K | $134.0K | $2.0K | $195.0K | $195.0K | $143.0K | $154.2K | $158.0K | $146.1K | $107.0K |
| Inventory | - | - | $16.0K | $16.0K | $15.0K | $21.0K | $50.9K | $106.3K | $104.0K | $121.5K |
| Accounts Payable | $23.0K | $6.0K | $34.0K | $31.0K | $30.0K | $48.0K | $32.8K | $25.0K | $161.4K | $43.5K |
| Current Assets | $8.22M | $6.01M | $8.66M | $5.02M | $4.33M | $3.40M | $3.37M | $5.46M | $4.42M | $5.47M |
| Total Assets | $16.40M | $20.41M | $11.03M | $7.75M | $7.37M | $5.46M | $5.82M | $7.48M | $6.27M | $7.24M |
| Current Liabilities | $1.74M | $1.43M | $2.06M | $1.06M | $976.0K | $892.0K | $517.4K | $1.59M | $560.6K | $778.5K |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $3.54M | $4.67M | $2.35M | $2.20M | $3.67M | $892.0K | $518.8K | $1.59M | $565.8K | $785.7K |
| Stockholders' Equity | $12.97M | $16.01M | $8.93M | $5.76M | $3.94M | $4.75M | $5.44M | $5.97M | $5.77M | $6.48M |
| Retained Earnings | ($45.14M) | ($38.56M) | ($39.83M) | ($40.26M) | ($35.75M) | ($34.55M) | ($33.18M) | ($30.92M) | ($30.13M) | ($29.36M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($1.42M) | - | - | - | ($809.0K) | - | - | - | ($1.01M) | - |
| Investing Cash Flow | ($450.0K) | - | - | - | ($1.18M) | - | - | - | - | - |
| Financing Cash Flow | $2.20M | - | - | - | $2.53M | - | - | - | $40.0K | - |
| CapEx | $71.0K | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | ($1.49M) | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | 0.0% | - | 78.8% | - | -743.2% | 65.1% | 36.2% | - |
| Operating margin | - | - | -66300.0% | - | -937.9% | - | -17023.2% | -5235.2% | -2051.2% | - |
| EBITDA margin | - | - | - | - | -933.3% | - | - | - | -2039.5% | - |
| Net margin | - | - | 21450.0% | - | -1807.6% | - | -24859.5% | -4759.1% | -1755.8% | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | 0.23 | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | 2600.0% | - | 30.3% | - | 1344.6% | 70.7% | 264.3% | - |
| SG&A / Revenue | - | - | 62000.0% | - | 915.2% | - | 14223.6% | 4884.9% | 1692.4% | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -40.1% | - | 3.9% | -58.2% | -16.2% | - | -38.9% | -10.5% | -12.3% | - |
| Return on equity | -50.7% | - | 4.8% | -78.2% | -30.3% | - | -41.6% | -13.2% | -13.3% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 4.73 | 4.19 | 4.21 | 4.73 | 4.44 | 3.82 | 6.52 | 3.43 | 7.89 | 7.02 |
| Quick ratio | 4.73 | 4.19 | 4.20 | 4.72 | 4.43 | 3.79 | 6.42 | 3.37 | 7.70 | 6.86 |
| Cash ratio | 2.47 | 2.67 | 2.94 | 2.96 | 2.79 | 2.45 | 5.31 | 2.81 | 6.23 | 5.71 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.26 | 1.27 | 1.23 | 1.34 | 1.87 | 1.15 | 1.07 | 1.25 | 1.09 | 1.12 |
| Liabilities / Assets | 0.22 | 0.23 | 0.21 | 0.28 | 0.50 | 0.16 | 0.09 | 0.21 | 0.09 | 0.11 |
| Efficiency | ||||||||||
| Asset turnover | - | - | 0.00 | - | 0.01 | - | 0.00 | 0.00 | 0.01 | - |
| Inventory turnover | - | - | 0.13 | 0.13 | 0.93 | - | 1.51 | 0.05 | 0.27 | - |
| Days sales outstanding | - | - | 365d | - | 1078d | - | 6182d | 3485d | 1216d | - |
| Days inventory outstanding | - | - | 2920d | 2920d | 391d | - | 242d | 6713d | 1357d | - |
| Days payable outstanding | - | - | 6205d | 5658d | 782d | - | 156d | 1576d | 2106d | - |
| Cash conversion cycle | - | - | -2920d | - | 687d | - | 6268d | 8621d | 467d | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | -78.0% | - | 50.6% | - | - | -54.8% | -63.8% | - |
| Revenue CAGR (3y) | - | - | -66.1% | - | -9.0% | - | -49.7% | -32.8% | -29.1% | - |
| Revenue CAGR (5y) | - | - | - | - | 0.8% | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | 228.1% | - | - | 12.1% | -79.7% | - |
| Operating income growth (YoY) | -1228.8% | - | 14.4% | -226.9% | 31.2% | - | 45.8% | -3.1% | 48.4% | - |
| Net income growth (YoY) | -451.6% | - | - | -472.6% | -55.0% | - | 4.3% | -11.0% | 55.1% | - |
| EPS growth (YoY) | -2653.8% | - | - | 21.7% | -50.0% | - | 78.1% | -130.0% | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 229.2% | 237.1% | 64.1% | -3.5% | -31.8% | -26.7% | 18.6% | 5.1% | 18.0% | 10.8% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2024-12-31.
Geographic
$210.0K totalUS$171.0K · 81.4%
IL$31.0K · 14.8%
PE$8.0K · 3.8%
Peer comparison
Same SIC group: Pharmaceutical Preparations
Comparing Save Foods against the 5 most active filers in the same SIC group.